Dana-Farber to hold a discussion for cancer patients and survivors about Covid-19 vaccine

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm. Physicians from Dana-Farber will discuss common concerns and questions cancer patients and survivors have about the vaccine.

“While much information is publicly available, we know that cancer patients and survivors, and their families, have specific questions and want detailed information about the implications and availability of the vaccine,” said Steven R. Singer, chief communications officer, Dana-Farber. “We have an excellent panel of specialists and hope that this discussion will be a good resource for them.”

The discussion will be led by Dana-Farber leaders, including:

Craig Bunnell, MD

Chief Medical Officer

Anne Gross, PhD, RN

Senior Vice President Patient Care and Chief Nursing Officer

Meghan Baker, MD, ScD

Hospital Epidemiologist

Following brief presentations, the panelists will answer questions from attendees.

The link to participate in the discussion is here., and attendees may submit questions for the speakers in advance here.

A recording of the Forum will be posted on the Dana-Farber website, where additional information about Covid-19 vaccines for cancer patients is located.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.